Literature DB >> 19630768

Embryonic stem cell models in vascular biology.

X Li1, L Claesson-Welsh.   

Abstract

Embryonic stem cells have become an established tool in vascular biology to study the details of vasculogenesis as well as angiogenesis. There is also a future potential in using embryonic stem cell-derived endothelial cells for therapeutic purposes. It is important to evaluate this model by comparing features of endothelial cells derived from differentiating stem cells and their responsiveness to external stimuli to those of primary endothelial cells and to in vivo models. Through culture of mouse embryonic stem cell we discovered that differentiating stem cells are highly amenable to analyzing biochemical and cell biologic processes that are independent of flow. Endothelial cell function can be studied in the context of mutations or deletions that are embryonically lethal in vivo. Many, if not all, of the features of sprouting angiogenesis in differentiating stem cells closely mimic the in vivo process.

Entities:  

Mesh:

Year:  2009        PMID: 19630768     DOI: 10.1111/j.1538-7836.2009.03427.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  6 in total

1.  Endothelial cells expressing low levels of CD143 (ACE) exhibit enhanced sprouting and potency in relieving tissue ischemia.

Authors:  Eduardo A Silva; Chikezie Eseonu; David J Mooney
Journal:  Angiogenesis       Date:  2014-01-11       Impact factor: 9.596

2.  Hypoxia influences the vascular expansion and differentiation of embryonic stem cell cultures through the temporal expression of vascular endothelial growth factor receptors in an ARNT-dependent manner.

Authors:  Yu Han; Shu-Zhen Kuang; Alla Gomer; Diana L Ramirez-Bergeron
Journal:  Stem Cells       Date:  2010-04       Impact factor: 6.277

3.  Hesperidin Inhibits Vascular Formation by Blocking the AKT/mTOR Signaling Pathways.

Authors:  Gi Dae Kim
Journal:  Prev Nutr Food Sci       Date:  2015-12-31

4.  ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis.

Authors:  Zhen Liu; Franck Lebrin; Janita A Maring; Sander van den Driesche; Stieneke van der Brink; Maarten van Dinther; Midory Thorikay; Sabrina Martin; Kazuki Kobayashi; Lukas J A C Hawinkels; Laurens A van Meeteren; Evangelia Pardali; Jeroen Korving; Michelle Letarte; Helen M Arthur; Charles Theuer; Marie-José Goumans; Christine Mummery; Peter ten Dijke
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

5.  Novel role of p73 as a regulator of developmental angiogenesis: Implication for cancer therapy.

Authors:  Maria C Marin; Margarita M Marques
Journal:  Mol Cell Oncol       Date:  2015-05-26

6.  p73 is required for vessel integrity controlling endothelial junctional dynamics through Angiomotin.

Authors:  Laura Maeso-Alonso; Hugo Alonso-Olivares; Nicole Martínez-García; Lorena López-Ferreras; Javier Villoch-Fernández; Laura Puente-Santamaría; Natalia Colas-Algora; Alfonso Fernández-Corona; María Elena Lorenzo-Marcos; Benilde Jiménez; Lars Holmgren; Margareta Wilhelm; Jaime Millan; Luis Del Peso; Lena Claesson-Welsh; Margarita M Marques; Maria C Marin
Journal:  Cell Mol Life Sci       Date:  2022-10-01       Impact factor: 9.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.